Physician

Neeraj Roshanial Sharma, MD

According to 2025 Medicare claims, Neeraj Sharma, MD (NPI: 1851334759) practices medical oncology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 75601-4717.

Sharma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 907 traditional Medicare patients, billed 153,540 HCPCS/CPT codes, and received $2,127,408 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,202 prescription claims across 328 beneficiaries totaling $5,298,196 in drug costs, led by Revlimid (Lenalidomide). DME data shows 44 claims. Open Payments data shows 37 records totaling $2,037. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,200,736 to $2,127,408. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $945,271 to $5,298,196. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $9,158 to $13,358.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $1,200,736 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,369,771 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,654,374 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,604,142 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,576,507 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,529,269 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,034,015 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,903,891 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,787,519 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,127,408 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201557874,012$1,200,736
201679084,327$1,369,771
2017858115,755$1,654,374
2018952164,691$2,604,142
20191,109236,158$3,576,507
20201,140227,399$3,529,269
2021993188,542$3,034,015
2022911183,713$2,903,891
2023856188,131$2,787,519
2024907153,540$2,127,408

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.6M$5.3M2015 Drug cost: $945,271 (USD; Tot_Drug_Cst)2016 Drug cost: $1,275,862 (USD; Tot_Drug_Cst)2017 Drug cost: $2,033,661 (USD; Tot_Drug_Cst)2018 Drug cost: $2,714,287 (USD; Tot_Drug_Cst)2019 Drug cost: $2,448,971 (USD; Tot_Drug_Cst)2020 Drug cost: $2,411,058 (USD; Tot_Drug_Cst)2021 Drug cost: $2,950,480 (USD; Tot_Drug_Cst)2022 Drug cost: $3,197,333 (USD; Tot_Drug_Cst)2023 Drug cost: $3,846,899 (USD; Tot_Drug_Cst)2024 Drug cost: $5,298,196 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152481,692$945,271
20162261,572$1,275,862
20172441,753$2,033,661
20182881,919$2,714,287
20193061,841$2,448,971
20203612,088$2,411,058
20213602,020$2,950,480
20223061,931$3,197,333
20233141,982$3,846,899
20243282,202$5,298,196

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$13K$26K2015 Medicare payment: $26,183 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $287 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $418 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,743 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,838 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $11,481 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $10,844 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R168$26,183
2016N/R14$287
2017N/RN/RN/R
2018N/R11$418
2019N/R46$4,743
2020N/R11$1,838
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R28$11,481
2024N/R44$10,844

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more189512$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more307611$58
80053Blood test, comprehensive group of blood chemicals4351,234$10
36415Insertion of needle into vein for collection of blood sample4381,714$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4271,570$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide1022,555$1,532,683
ImbruvicaIbrutinib33924$537,237
ErleadaApalutamide351,050$492,697
LenalidomideLenalidomide33819$427,788
JakafiRuxolitinib Phosphate22660$381,999

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A6010Collagen based wound filler, dry form, sterile, per gram of collagenNN/R13$10,039
J8521Capecitabine, oral, 500 mgNN/R11$447
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R20$358

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.37$2,037PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Neeraj Roshanial Sharma, MD?

Tedicare shows public-source Medicare data for Neeraj Roshanial Sharma, MD (NPI 1851334759), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neeraj Roshanial Sharma, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Neeraj Roshanial Sharma, MD?

Neeraj Roshanial Sharma, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Neeraj Roshanial Sharma, MD have Open Payments data?

Neeraj Roshanial Sharma, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.